Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • baalhadad baalhadad Nov 27, 2007 10:27 PM Flag

    Growth in the non-Lipitor component in 2010-2012

    1) Non-Lipitor component will also suffer massive patent losses.

    2) Lipitor won't retain 20% of sales after going off patent. It probably won't even keep 10%.

    3) $2.49 EPS consensus for 2009 - (your 82 cents / 10 = 8 cents, leaving 74 cents) = $1.75 - (90% of another 22 cents going off patent) = $1.55, plus 15 cents per year average gain in 2010, 2011 & 2012 = $2.00 EPS for 2012, ie ~same as analysts' current consensus.

 
PFE
34.82-0.27(-0.77%)Aug 24 4:00 PMEDT